IN2014DN11097A - - Google Patents

Download PDF

Info

Publication number
IN2014DN11097A
IN2014DN11097A IN11097DEN2014A IN2014DN11097A IN 2014DN11097 A IN2014DN11097 A IN 2014DN11097A IN 11097DEN2014 A IN11097DEN2014 A IN 11097DEN2014A IN 2014DN11097 A IN2014DN11097 A IN 2014DN11097A
Authority
IN
India
Prior art keywords
particles
titanium
micrometer
cavities
exhibit
Prior art date
Application number
Other languages
English (en)
Inventor
Lars Magnus Bjursten
Sven Erik Nilsson
Original Assignee
Migrata U K Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Migrata U K Ltd filed Critical Migrata U K Ltd
Publication of IN2014DN11097A publication Critical patent/IN2014DN11097A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0419—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
IN11097DEN2014 2012-06-04 2013-05-29 IN2014DN11097A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261655093P 2012-06-04 2012-06-04
SE1250582 2012-06-04
PCT/SE2013/050620 WO2013184061A1 (en) 2012-06-04 2013-05-29 Medical use of particles of titanium and/or titanium oxide

Publications (1)

Publication Number Publication Date
IN2014DN11097A true IN2014DN11097A (cg-RX-API-DMAC7.html) 2015-09-25

Family

ID=49712337

Family Applications (1)

Application Number Title Priority Date Filing Date
IN11097DEN2014 IN2014DN11097A (cg-RX-API-DMAC7.html) 2012-06-04 2013-05-29

Country Status (5)

Country Link
US (1) US20150139913A1 (cg-RX-API-DMAC7.html)
EP (1) EP2854868A4 (cg-RX-API-DMAC7.html)
CN (1) CN104736184A (cg-RX-API-DMAC7.html)
IN (1) IN2014DN11097A (cg-RX-API-DMAC7.html)
WO (1) WO2013184061A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3984560A1 (en) * 2013-03-15 2022-04-20 The Regents of the University of California Enteric ct contrast material based on low-z atoms
JP2016528259A (ja) 2013-08-16 2016-09-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア シリコーン系腸管ｃｔ造影材料
CN113456839B (zh) * 2021-07-05 2022-06-21 浙江大学 一种偶极共振增强的双负型声学超材料及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4020152A (en) * 1973-12-18 1977-04-26 Thann & Mulhouse Barium titanate and barium zirconate in radiological contrast products
EP0253554A3 (en) * 1986-07-15 1988-07-20 Pfizer Inc. Controlled release drug-containing fibers
GB9204388D0 (en) * 1992-02-29 1992-04-15 Tioxide Specialties Ltd Water-in-oil emulsions
US5593657A (en) * 1995-02-09 1997-01-14 Nanosystems L.L.C. Barium salt formulations stabilized by non-ionic and anionic stabilizers
US6024569A (en) * 1998-11-06 2000-02-15 Aytec Japan Corporation Root canal filling point
SE515227C2 (sv) * 1999-04-28 2001-07-02 Bruce Medical Ab Kropp för åstadkommande av in- och tillväxt av benvävnad och/ eller bindväv och sätt för framställning av kroppen
DE10018405B4 (de) * 2000-04-13 2004-07-08 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Sphärische oxidische Partikel und deren Verwendung
US6394965B1 (en) * 2000-08-15 2002-05-28 Carbon Medical Technologies, Inc. Tissue marking using biocompatible microparticles
ATE541595T1 (de) * 2002-03-22 2012-02-15 Kuros Biosurgery Ag Zusammensetzung für die verstärkung von hartem gewebe
US8012454B2 (en) * 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
JP4474878B2 (ja) * 2003-09-17 2010-06-09 株式会社Ｉｈｉ Ｘ線造影剤、ｘ線造影剤の製造方法
JP2008518873A (ja) * 2004-11-02 2008-06-05 ナノゲート エージー 二酸化チタンナノ粒子の合成
SE531318C2 (sv) * 2007-02-22 2009-02-24 Tigran Technologies Ab Publ Injicerbar suspension innefattande titan-,titanlegerings- eller titanoxidpartiklar av mikrostruktur
JP2008297289A (ja) * 2007-06-04 2008-12-11 Canon Inc 造影剤及びその製造方法
WO2010039799A1 (en) * 2008-09-30 2010-04-08 Sabic Innovative Plastics Ip B.V. X-ray and/or metal detectable articles and method of making the same
GB0921596D0 (en) * 2009-12-09 2010-01-27 Isis Innovation Particles for the treatment of cancer in combination with radiotherapy
WO2011084625A1 (en) * 2009-12-16 2011-07-14 Georgia Tech Research Corporation Systems and methods for x-ray flourescence computed tomography imaging with nanoparticles

Also Published As

Publication number Publication date
EP2854868A1 (en) 2015-04-08
EP2854868A4 (en) 2016-01-20
WO2013184061A1 (en) 2013-12-12
US20150139913A1 (en) 2015-05-21
CN104736184A (zh) 2015-06-24

Similar Documents

Publication Publication Date Title
CA2865972C (en) Inhalable dry powders
IL255113A0 (en) Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
WO2012121528A3 (en) Magnetic nanocomposite specific for thyroid cancer and use thereof
EP2833721A4 (en) NICKEL OXIDE RELEASING PHARMACEUTICAL COMPOSITIONS
IL223889B (en) Contrasting side effects associated with the administration of an anti-hyaluronan factor and methods for alleviating or preventing the side effects
EP3686184A3 (en) Ionizable compounds and compositions and uses thereof
MX2019000225A (es) Composiciones y metodos para el tratamiento de enfermedades autoinmunes y otras enfermedades.
EP3861982A3 (en) Intracameral implant for treatment of an ocular condition
IL234101B (en) Preparations containing acamprosate and baclofen for use in the treatment of Parkinson's disease
WO2012138379A3 (en) Multifunctional chelator-free radioactive nanoparticles for imaging and therapy
BR112012004967A2 (pt) forma de dosagem oral, compreendendo pelo menos um agente biologicamente ativo, substâncias auxiliares da formulação e partículas magnetizáveis
EP3052191A4 (en) Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic lateral sclerosis (als)
SG11201510021TA (en) Compositions and methods for use in medical diagnosis
PT2523674E (pt) Composições compreendendo extratos de andrographis paniculata combinados com extratos de ginkgo biloba complexados com fosfolípidos, e suas utilizações
CA2927016C (en) Oral care composition
JP2012528941A5 (cg-RX-API-DMAC7.html)
IN2014DN11097A (cg-RX-API-DMAC7.html)
PT2603238E (pt) Métodos e composições farmacêuticas para o tratamento de uma doença ocular num indíviduo
WO2015073177A8 (en) Vaginal inserted estradiol pharmaceutical compositons and methods
ZA201503604B (en) Fibrinolytic compositions comprising bromelain and nattokinase for the prevention and treatment of phlebothrombotic states
EP4233915A3 (en) Modified release formulations of viloxazine
MX2018004445A (es) Particulas coloidales para su uso en medicina.
WO2015054208A8 (en) Injectable compositions
EP2880103A4 (en) OXID-COATED METAL PIGMENTS AND FILM-FORMING COMPOSITIONS
PL2895192T3 (pl) Kompozycja farmaceutyczna zawierająca stałą nanocząstkę i co najmniej antygen do leczenia przeciwko wewnątrzkomórkowemu czynnikowi patogennemu